US Patent Issued on Aug. 18 for "Engineered adenovirus vectors and uses thereof" (California Inventor)

ALEXANDRIA, Va., Aug. 18 -- United States Patent no. 12,709,761, issued on Aug. 18.

"Engineered adenovirus vectors and uses thereof" was invented by Richard Lowenthal (San Diego).

According to the abstract* released by the U.S. Patent & Trademark Office: "Disclosed herein relates to a replication competent recombinant adenovirus comprising restriction enzyme sites in an E3 region to insert a gene of interest. Also disclosed herein is a method for generating the replication competent recombinant adenovirus and a pharmaceutical composition comprising the adenovirus for use in treating a disease or a condition."

The patent was filed on Dec. 1, 2022, under Application No. 18/060,776.

*For further information, including images, charts and ta...